These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8891737)

  • 21. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients.
    Creput C; Le Friec G; Bahri R; Amiot L; Charpentier B; Carosella E; Rouas-Freiss N; Durrbach A
    Hum Immunol; 2003 Nov; 64(11):1033-8. PubMed ID: 14602232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and immunological evaluation of donor-specific soluble HLA in the circulation of liver transplant recipients.
    Mathew JM; Shenoy S; Phelan D; Lowell J; Howard T; Mohanakumar T
    Transplantation; 1996 Jul; 62(2):217-23. PubMed ID: 8755819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients.
    Zavazava N; Böttcher H; Ruchholtz WM
    Tissue Antigens; 1993 Jul; 42(1):20-6. PubMed ID: 8248891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
    Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
    Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
    Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
    Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Applications of monitoring human leukocyte antigen G and its inhibitory receptors in post-renal transplantation].
    XIAO L; SHI BY; GAO Y; CAI M; Qian YY; HE XY; XU XG; HAN Y; ZHOU WQ; MENG XY; HAN MX
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(36):2524-7. PubMed ID: 21092455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
    Schweizer RT; Roper L; Hull D; Bartus SA
    Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
    Kandus A; Grego K; Bren AF
    Ther Apher Dial; 2005 Jun; 9(3):262-4. PubMed ID: 15967003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of conversion from triple-drug to double-drug therapy in living related renal transplantation.
    Agarwal SK; Dash SC; Tiwari SC; Saxena S; Mehta S; Guleria S; Dwivedi SN; Mehra NK
    Transplantation; 1995 Jan; 59(1):27-31. PubMed ID: 7839425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of induction therapy HLA matching and T- and B-cell crossmatch on the long-term outcome of living donated renal transplantation.
    Lumlertgul D; Manoyos A; Saikum U; Chaovisitsaree A; Boonkaew S; Wongsawad P; Bunnachak D; Roachanapiwat B; Wutikarn S
    Transplant Proc; 1998 Aug; 30(5):1801-4. PubMed ID: 9723290
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
    Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
    Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azathioprine vs cyclosporine in recipients of HLA-identical renal allografts.
    Gill IS; Hodge EE; Novick AC; Streem SB; Braun WE; Paranandi L
    Cleve Clin J Med; 1994; 61(3):206-10. PubMed ID: 8026064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants.
    Sasaki N; Idica A; Hall B; Terasaki PI
    Clin Transpl; 2008; ():241-52. PubMed ID: 19711515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum soluble HLA class I antigen levels in hemodialysis patients and following renal transplantation.
    Yang CW; Kim TG; Kim YS; Han H; Chang YS; Yoon YS; Bang BK
    Am J Nephrol; 1995; 15(4):290-4. PubMed ID: 7573185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection.
    Gill JS; Landsberg D; Johnston O; Shapiro RJ; Magil AB; Wu V; Tinckam K; Keown P
    Transplantation; 2010 Jan; 89(2):178-84. PubMed ID: 20098280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection.
    Puppo F; Pellicci R; Brenci S; Nocera A; Morelli N; Dardano G; Bertocchi M; Antonucci A; Ghio M; Scudeletti M
    Hum Immunol; 1994 Jul; 40(3):166-70. PubMed ID: 7960957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.